Literature DB >> 29420694

L1000FWD: fireworks visualization of drug-induced transcriptomic signatures.

Zichen Wang1, Alexander Lachmann1, Alexandra B Keenan1, Avi Ma'ayan1.   

Abstract

Motivation: As part of the NIH Library of Integrated Network-based Cellular Signatures program, hundreds of thousands of transcriptomic signatures were generated with the L1000 technology, profiling the response of human cell lines to over 20 000 small molecule compounds. This effort is a promising approach toward revealing the mechanisms-of-action (MOA) for marketed drugs and other less studied potential therapeutic compounds.
Results: L1000 fireworks display (L1000FWD) is a web application that provides interactive visualization of over 16 000 drug and small-molecule induced gene expression signatures. L1000FWD enables coloring of signatures by different attributes such as cell type, time point, concentration, as well as drug attributes such as MOA and clinical phase. Signature similarity search is implemented to enable the search for mimicking or opposing signatures given as input of up and down gene sets. Each point on the L1000FWD interactive map is linked to a signature landing page, which provides multifaceted knowledge from various sources about the signature and the drug. Notably such information includes most frequent diagnoses, co-prescribed drugs and age distribution of prescriptions as extracted from the Mount Sinai Health System electronic medical records. Overall, L1000FWD serves as a platform for identifying functions for novel small molecules using unsupervised clustering, as well as for exploring drug MOA. Availability and implementation: L1000FWD is freely accessible at: http://amp.pharm.mssm.edu/L1000FWD. Supplementary information: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Year:  2018        PMID: 29420694      PMCID: PMC6454499          DOI: 10.1093/bioinformatics/bty060

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  44 in total

1.  Predicting mechanism of action of cellular perturbations with pathway activity signatures.

Authors:  Yan Ren; Siva Sivaganesan; Nicholas A Clark; Lixia Zhang; Jacek Biesiada; Wen Niu; David R Plas; Mario Medvedovic
Journal:  Bioinformatics       Date:  2020-09-15       Impact factor: 6.937

2.  Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19.

Authors:  Md Rabiul Auwul; Md Rezanur Rahman; Esra Gov; Md Shahjaman; Mohammad Ali Moni
Journal:  Brief Bioinform       Date:  2021-04-12       Impact factor: 11.622

3.  Getting Started with LINCS Datasets and Tools.

Authors:  Zhuorui Xie; Eryk Kropiwnicki; Megan L Wojciechowicz; Kathleen M Jagodnik; Ingrid Shu; Allison Bailey; Daniel J B Clarke; Minji Jeon; John Erol Evangelista; Maxim V Kuleshov; Alexander Lachmann; Abhijna A Parigi; Jose M Sanchez; Sherry L Jenkins; Avi Ma'ayan
Journal:  Curr Protoc       Date:  2022-07

4.  Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.

Authors:  Marios Tomazou; Marilena M Bourdakou; George Minadakis; Margarita Zachariou; Anastasis Oulas; Evangelos Karatzas; Eleni M Loizidou; Andrea C Kakouri; Christiana C Christodoulou; Kyriaki Savva; Maria Zanti; Anna Onisiforou; Sotiroula Afxenti; Jan Richter; Christina G Christodoulou; Theodoros Kyprianou; George Kolios; Nikolas Dietis; George M Spyrou
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

5.  KEA3: improved kinase enrichment analysis via data integration.

Authors:  Maxim V Kuleshov; Zhuorui Xie; Alexandra B K London; Janice Yang; John Erol Evangelista; Alexander Lachmann; Ingrid Shu; Denis Torre; Avi Ma'ayan
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

6.  Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential Therapeutics.

Authors:  Broto Chakrabarty; Dibyajyoti Das; Gopalakrishnan Bulusu; Arijit Roy
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2021-08-06       Impact factor: 3.702

7.  SigCom LINCS: data and metadata search engine for a million gene expression signatures.

Authors:  John Erol Evangelista; Daniel J B Clarke; Zhuorui Xie; Alexander Lachmann; Minji Jeon; Kerwin Chen; Kathleen M Jagodnik; Sherry L Jenkins; Maxim V Kuleshov; Megan L Wojciechowicz; Stephan C Schürer; Mario Medvedovic; Avi Ma'ayan
Journal:  Nucleic Acids Res       Date:  2022-05-07       Impact factor: 19.160

8.  Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.

Authors:  Hui-Wen Lue; Daniel S Derrick; Soumya Rao; Ahna Van Gaest; Larry Cheng; Jennifer Podolak; Samantha Lawson; Changhui Xue; Devin Garg; Ralph White; Christopher W Ryan; Justin M Drake; Anna Ritz; Laura M Heiser; George V Thomas
Journal:  Cell Rep Med       Date:  2021-05-07

9.  Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.

Authors:  Elmira R Vagapova; Timofey D Lebedev; Vladimir S Prassolov
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

10.  Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases.

Authors:  Panagiotis Garantziotis; Stavros A P Doumas; Ioannis Boletis; Eleni Frangou
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.